Alleviation of depression by glucagon-like peptide 1 through the regulation of neuroinflammation, neurotransmitters, neurogenesis, and synaptic function
Reductions in BMI, waist circumference, FPG, HbA1c, and blood pressure were observed, indicating broad metabolic benefits
[3] [5] If you are participating in a clinical trial involving an investigational GLP-1 patch, you must contact your research team immediately for specific instructions if your patch becomes detached
This raises major concerns about safety, dosing, and quality control
Market expansion is being supported by the growing recognition of obesity as a chronic disease requiring pharmacological intervention and the compelling clinical evidence demonstrating substantial cardiovascular risk reduction in treated populations